Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan

JACC Heart Fail. 2023 Jul;11(7):855-858. doi: 10.1016/j.jchf.2023.03.006. Epub 2023 Apr 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminobutyrates / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure* / drug therapy
  • Humans
  • Natriuretic Peptide, Brain
  • Natriuretic Peptides
  • Phenotype
  • Stroke Volume
  • Tetrazoles / therapeutic use
  • Valsartan

Substances

  • sacubitril
  • Valsartan
  • Aminobutyrates
  • Biphenyl Compounds
  • Drug Combinations
  • Natriuretic Peptides
  • Angiotensin Receptor Antagonists
  • Tetrazoles
  • Natriuretic Peptide, Brain